Search by Drug Name or NDC
NDC 43386-0030-01 Monobasic Sodium Phosphate and Dibasic Sodium Phosphate .398; 1.105 g/1; g/1 Details
Monobasic Sodium Phosphate and Dibasic Sodium Phosphate .398; 1.105 g/1; g/1
Monobasic Sodium Phosphate and Dibasic Sodium Phosphate is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Lupin Pharmaceuticals,Inc.. The primary component is SODIUM PHOSPHATE, DIBASIC, ANHYDROUS; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE.
MedlinePlus Drug Summary
Sodium phosphate is used in adults 18 years of age or older to empty the colon (large intestine, bowel) before a colonoscopy (examination of the inside of the colon to check for colon cancer and other abnormalities) so that the doctor will have a clear view of the walls of the colon. Sodium phosphate is in a class of medications called saline laxatives. It works by causing diarrhea so that the stool can be emptied from the colon.
Related Packages: 43386-0030-01Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Sodium Phosphate
Product Information
| NDC | 43386-0030 |
|---|---|
| Product ID | 43386-030_b1062fe4-a424-4354-a204-f4dcefe33bf4 |
| Associated GPIs | |
| GCN Sequence Number | n/a |
| GCN Sequence Number Description | n/a |
| HIC3 | n/a |
| HIC3 Description | n/a |
| GCN | n/a |
| HICL Sequence Number | n/a |
| HICL Sequence Number Description | n/a |
| Brand/Generic | n/a |
| Proprietary Name | Monobasic Sodium Phosphate and Dibasic Sodium Phosphate |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Monobasic Sodium Phosphate and Dibasic Sodium Phosphate |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET |
| Route | ORAL |
| Active Ingredient Strength | .398; 1.105 |
| Active Ingredient Units | g/1; g/1 |
| Substance Name | SODIUM PHOSPHATE, DIBASIC, ANHYDROUS; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE |
| Labeler Name | Lupin Pharmaceuticals,Inc. |
| Pharmaceutical Class | Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Activity [MoA], |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA079247 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 43386-0030-01 (43386003001)
| NDC Package Code | 43386-030-01 |
|---|---|
| Billing NDC | 43386003001 |
| Package | 100 TABLET in 1 BOTTLE (43386-030-01) |
| Marketing Start Date | 2012-01-20 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |